Out of Cash and Unable to Pin Down a Partnership, Akceli Shuts Down Operations | GenomeWeb

For the past few weeks, anyone trying to get in contact with microarray developer Akceli has been out of luck — the company’s phones are disconnected, its website is down, and messages to corporate e-mail accounts get bounced back.

As it turns out, the company has folded after being unable to find new investors and failing to generate sufficient revenues to fund operations, according to Rockefeller University researcher Thomas Tuschl, who was a member of Akceli’s scientific advisory board.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.